CRB’s Horizons series of industry reports pools the talents and expertise of our leading subject matter experts to understand the conditions and forces affecting the life sciences and food and beverage industries. Based on hundreds of surveys of industry leaders, our free reports go deep on the critical trends driving the markets and how companies can stay on the leading edge.
Download Now – Horizons: Life Sciences
Our 2022 edition of the life sciences report, built on the insights of nearly 500 industry leaders, explores the transformative change this field is poised to undergo in the wake of the pandemic and ever-increasing investment in R&D.
2022 Life Sciences Report
This report explores an industry that is investing in novel research, pushing against long-established comfort zones, and moving cautiously but steadily toward an advanced standard of care for critically ill patients.Read More
2021 Life Sciences Report
We explore the disruptive forces reshaping how biopharma companies speed life-saving therapies and vaccines to the market.Read More
2020 Cell & Gene Therapy Report
Through a survey of nearly 150 industry leaders, our inaugural CRB Horizons: Cell and Gene Therapy report finds the biopharma space at a critical inflection point.Read More